CLINICAL TRIALS PROFILE FOR FOSINOPRIL SODIUM
✉ Email this page to a colleague
All Clinical Trials for fosinopril sodium
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00776334 ↗ | Bioequivalence Study of Fosinopril 40mg Tablets Under Fasting Conditions | Completed | Ranbaxy Laboratories Limited | N/A | 2002-10-01 | The objective of this study is to compare the relative bioavailability of fosinopril sodium 40 mg tablets (Ranbaxy Laboratories Limited, Lot No. 1238312) with that of Monopril® in healthy adult subjects under fasting conditions. |
NCT00776672 ↗ | Bioequivalence Study of Fosinopril 40mg Tablets Under Fed Conditions | Completed | Ranbaxy Laboratories Limited | N/A | 2002-10-01 | The objective of this study is to compare the relative bioavailability of fosinopril sodium 40 mg tablets (Ranbaxy Laboratories Limited, Lot No. 1238312) with that of Monopril® in healthy adult subjects under non-fasting conditions. |
NCT00777972 ↗ | Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions | Completed | Ranbaxy Laboratories Limited | N/A | 2003-03-01 | The objective of this study was to compare the relative bioavailability of Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets by Ranbaxy Laboratories Limited with that of Monopril ®.-HCT 20-12.5 mg tablets by Bristol-Meyers Squibb following a single oral dose (1 x 20-12.5 mg tablet) in healthy adult subjects under fasting conditions |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for fosinopril sodium
Condition Name
Clinical Trial Locations for fosinopril sodium
Trials by Country
Clinical Trial Progress for fosinopril sodium
Clinical Trial Phase
Clinical Trial Sponsors for fosinopril sodium
Sponsor Name